Related Experiment Video
Updated: Jan 17, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis
Carla Gaggiano1, Alejandra De-la-Torre2, Juanita Cardona-López2
1Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena University Hospital [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], Policlinico "Le Scotte", Viale Bracci 16, 53100, Siena, Italy.
Insights
Pediatric noninfectious uveitis complications are predicted by chronic, idiopathic, and non-anterior disease courses. Early immunosuppressive therapy initiation is crucial for preventing vision loss in at-risk children.
Area of Science:
- Ophthalmology
- Pediatric Rheumatology
- Immunology
Background:
- Pediatric-onset uveitis can lead to significant complications and visual impairment.
- Identifying predictors of complications is essential for timely intervention.
Purpose of the Study:
- To describe the complications of pediatric-onset noninfectious uveitis.
- To identify baseline and treatment-related predictors of these complications.
Main Methods:
- Registry-based observational study of 309 patients with noninfectious uveitis onset before age 18.
- Analysis of complications, including type, frequency, and associated factors.
- Multivariate analysis to determine independent predictors of complications and visual acuity.
Main Results:
- 44.3% of children developed at least one complication over a median follow-up of 49 months.
- Idiopathic uveitis, longer topical glucocorticoid monotherapy, and delayed immunosuppressive therapy (IST) increased complication risk.
- Anterior uveitis was protective, while chronic uveitis significantly increased risk. Panuveitis and cataract reduced final visual acuity.
Conclusions:
- Children with chronic, idiopathic, early-onset, non-anterior uveitis face the highest risk of complications.
- Structured screening and early systemic IST initiation are vital for preventing visual impairment in these children.
Introduction:
This study aims to describe complications of pediatric-onset uveitis and their predictors among baseline and treatment-related factors.
Methods:
This registry-based observational study included patients with noninfectious uveitis with disease onset < 18 years.
Results:
A total of 309 patients were enrolled (535 eyes). Uveitis was anterior in 290 eyes (54.2%), panuveitis in 121 (22.6%), intermediate in 88 (16.4%), and posterior in 24 (4.5%). Over a median follow-up of 49.0 months (interquartile range [IQR] 101.0), 137 children (44.3%) developed ≥ 1 complication (14.4 per 100 patient-years). Idiopathic uveitis (p < 0.001), longer topical glucocorticoid (GC) monotherapy (p < 0.001) and longer delay of immunosuppressive therapy (IST) (p = 0.03) were associated with a higher frequency of complications. In multivariate analysis, anterior uveitis was protective against complications (odds ratio [OR] 0.10, 95% confidence interval [CI] - 4.1 to - 1.6, p < 0.001), whereas a chronic course of uveitis significantly increased the risk (OR 6.13, 95% CI 1.0-2.6, p < 0.001). Older age at onset was protective against cataract (OR 0.91, 95% CI - 0.2 to - 0.02, p = 0.020) and band keratopathy (OR 0.8, 95% CI - 0.4 to - 0.1, p = 0.003). Final best-corrected visual acuity (BCVA) (Snellen decimals) was inversely correlated with the duration of topical GC monotherapy (ρ = - 0.23; p = 0.001). In multivariate analysis, panuveitis was linked to a 0.142 decimal reduction (95% CI - 0.219 to - 0.066, p < 0.001), and cataract to a 0.295 reduction (95% CI - 0.372 to - 0.217, p < 0.001) in the final BCVA.
Conclusions:
Children with chronic, idiopathic, early-onset, and non-anterior uveitis are at greatest risk for complications. Structured screening for these children, along with early initiation of systemic IST, is essential to prevent visual impairment.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

